FIELD TRIP HEALTH LTD.

Analyst Reco. Field Trip Health Ltd. Canadian Securities Exchange

Equities

FTRP

CA31656R1029

End-of-day quote Canadian Securities Exchange Other stock markets 23:00:00 07/07/2021 BST			5-day change	1st Jan Change
6.65 ^CAD	+6.40%		+0.36%	+32.78%

05-20	Reunion Neuroscience Announces Publication of Results from Early Preclinical Studies Demonstrating the Potential of Re104 for Development in Depressive Disorders	CI
05-02	Reunion Neuroscience Inc. Announces Advancing RE104, Its Proprietary, Clinical-Stage Serotonergic Psychedelic Drug Candidate to Provide Benefits to Patients with Underserved Mental Health Disorders	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ThinkEquity Initiates Reunion Neuroscience at Buy With $5 Price Target	01/05/23	MT
ThinkEquity Starts Reunion Neuroscience at Buy With $5 Price Target	01/05/23	MT
Reunion Neuroscience Downgraded to Hold at Stifel GMP as it Sues a Competitor; Price Target Cut to C$1.00	15/03/23	MT
EF Hutton Initiates Coverage on Reunion Neuroscience at Buy With $11 Price Target	16/12/22	MT
Reunion Neuroscience Kept at Speculative Buy at Stifel GMP After FQ2 Report; Price Target Cut 63% to C$5.00	15/11/22	MT
FIELD TRIP HEALTH : HC Wainwright Starts Field Trip Health at Buy with $20 Price Target	01/09/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer